Analysis of the 20S proteasome ChT-L activity in brain tumor patients depending on the IDH1 mutation found that IDH1 wild-type individuals had statistically higher proteasome activity compared to IDH1 mutants (p = 0.0261) (Fig 3). Here, IDH1 is linked to brain neoplasm.